The goal of our research is to define and advance the standard of care and improve survival and quality of life in cancer patients.

The principal objectives of SANTRO clinical trial include:

1. To increase survival in leading types of cancer by effective integration of local-regional therapy (with radiotherapy and/or surgical resection) and systemic therapy such as chemotherapy, molecular targeting therapy and hormonal treatment. To decrease morbidity from cancer and its treatments by protecting normal structures and preserving functions by optimized integration of surgery, chemotherapy, and radiation therapy.

2. To apply the state of art radiation technique such as 3-dimensional conformal radiation therapy, image-guided radiation therapy, intensity modulated radiation therapy, stereotactic radiosurgery and proton treatment etc to improve local-regional control and survival. To improve radiation therapy efficacy through optimal fractionation and/or chemical and biologic modification.

3. To develop translational research projects to better understand the fundamental nature of malignant processes and predict clinical outcome including efficacy and adverse effect of radiation therapy, hormone therapy, cytotoxic chemotherapy and molecular targeting therapy.

4. To define and advance the standard care of radiotherapy, chemotherapy and surgery and to disseminate these standards throughout the medical community in China for improved cancer control.

5. To help integrate clinical trials in China into other international collaborative research, thereby improving the quality of research and clinical care in China and the United States.

SANTRO provides an infrastructure for clinical investigators from the United States and China to seek collaborative research between China and the United States and pursue more effective treatments for cancer. SANTRO will help to establish mechanisms to initiate and approve clinical trial proposals, apply for research grant, monitor research process and assure compliance with protocols in all aspects of radiation therapy, dose prescription and delivery. The principal investigators of the study from SANTRO will be responsible for conducting, monitoring and reporting clinical trails. The principal investigators are required to be independent researcher and hold a faculty member position in academic institutions. Our research focus will be the common cancers in China and or the United States. You can submit your clinical trial concept using our online service. Concepts will be evaluated and scored by a panel of peer reviewers. The concept should be written in word file using either English or Chinese.